Literature DB >> 7108886

Myocardial infarction during asthmatic attack induced by ingestion of propranolol.

A B Millar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7108886      PMCID： PMC1438027          DOI： 10.1177/014107688207500817

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

1.  The beta-blocking effect of practolol in asthmatics.

Authors:  C Bernecker; I Roetscher
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

2.  Hypoxaemia in bronchial asthma.

Authors:  K N Palmer; M L Diament
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

3.  Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

Authors:  J M Raine; M G Palazzo; J H Kerr; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

4.  A comparison of the cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  M E Conolly; D A Warrell; J A Howes; J W Paterson; L J Beilin; D G Robertson; C T Dollery
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

5.  Myocardial infarction in status asthmaticus.

Authors:  A Szczeklik; R Nizankowski; J Mruk
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

6.  Severe asthma after inadvertent ingestion of oxprenolol.

Authors:  I P Williams; F J Millard
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

7.  Isoprenaline-induced changes in regional myocardial perfusion in the pathogenesis of myocardial necrosis.

Authors:  P Collins; C G Billings
Journal:  Br J Exp Pathol       Date:  1976-12

8.  Cigarette smoking in asthma.

Authors:  T W Higenbottam; C Feyeraband; T J Clark
Journal:  Br J Dis Chest       Date:  1980-07
  8 in total
  1 in total

1.  Safety and efficacy of alinidine in symptom-free asthmatics.

Authors:  J Lichey; M Hoffmann; H Huckauf; G Kammradt; T Friedrich
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.